Is the active ingredient in this medication.
Treatment of osteoporosis in postmenopausal women to reduce the risk of vertebral and hip fractures.
Treatment of Paget's disease of bone.
Treatment of bone metastases in patients with solid tumors.
Prevention of osteoporosis in men at high risk of fractures.
Idrofos 50mg Tab (Ibandronic Acid) is a bisphosphonate that works by inhibiting the activity of osteoclasts, the cells responsible for bone resorption. This slows down bone breakdown and allows for increased bone density.
Store at room temperature, away from light and moisture. Keep out of reach of children.
Dosage and frequency will vary based on the specific condition being treated and individual patient factors.
Ibandronic acid is typically administered orally or intravenously.
For oral administration, take with a full glass of water on an empty stomach at least 30 minutes before the first food or beverage of the day.
Do not lie down for at least 30 minutes after taking oral ibandronic acid.
For intravenous administration, the medication will be given by a healthcare professional.
It's crucial to follow your doctor's instructions closely regarding dosage and administration.
Common side effects include: headache, muscle pain, stomach upset, and constipation.
Serious side effects can include: jawbone problems, esophageal irritation, low calcium levels, and eye problems.
Avoid excessive alcohol consumption as it may increase the risk of side effects.
Ibandronic acid may cause dizziness or drowsiness. Avoid driving or operating machinery until you know how this medication affects you.
Ibandronic acid should not be used during pregnancy or breastfeeding.
Safety and effectiveness of ibandronic acid in children have not been established.
Patients with kidney problems may need adjusted dosages.
Liver disease may affect the metabolism of ibandronic acid.
https://www.mayoclinic.org/drugs-supplements/ibandronic-acid-oral-route/description/drg-20071514
https://www.drugs.com/mtm/ibandronic-acid.html
https://www.webmd.com/drugs/2/drug-15190/ibandronic-acid-oral/details
